Insights on Brain Bleeds, Stroke Recovery and Latest Neurosurgery Advancements

Actor Jamie Foxx’s recent health crisis, which involved a brain bleed and stroke that left him in a coma for 20 days, has drawn significant public attention. This serious medical event highlights the complexities of stroke recovery and the potential long-term effects on brain health. Alexander Khalessi, MD, MBA, chair of the Department of Neurological Surgery at University of California San Diego School of Medicine and neurosurgeon at UC San Diego Health, is available to provide expert insight into the latest research and treatment advancements for brain bleeds, as well as the neurological effects of stroke and rehabilitation.

Khalessi, who was recently appointed chair of the Advisory Council for Neurological Surgery at the American College of Surgeons (ACS), offers a unique perspective as the highest-ranking neurosurgeon in the ACS. This leadership position allows him to advocate for neurosurgeons and patients on a national level, making him an ideal expert to discuss the critical aspects of brain health.

Biography :

Alexander Khalessi, MD, MBA, is a board-certified neurosurgeon who specializes in complex cranial surgery, endovascular neurosurgery, stroke care, and neurological oncology. He is chair of the Department of Neurological Surgery at UC San Diego Health and professor of neurological surgery, radiology and neurosciences and the Don and Karen Cohn Chancellor’s Endowed Chair in Neurosurgery at UC San Diego School of Medicine.

Khalessi provides both open surgical and minimally invasive, catheter-based approaches to complex neurosurgical conditions, including brain tumors, aneurysms, arteriovenous malformations (AVM), carotid disease and ischemic stroke.

Khalessi is a founding member of the Medical Device Innovation Consortium (MDIC) that advises the FDA on early clinical feasibility for emerging neurovascular devices. He serves on the NIH Interventional Advisory Panel for StrokeNet, which provides scientific oversight for federally funded research in neurovascular disease.